COSMIC Cell Line Gene Mutation Profiles Dataset

Description gene mutations in cancer cell lines from low-throughput or high-throughput studies
Measurement gene mutation by data aggregation
Association gene-cell line associations by mutation of gene in cell line
Category genomics
Resource Catalogue of Somatic Mutations In Cancer
Citation(s)
Last Updated
Stats
  1. 17850 genes
  2. 1026 cell lines
  3. 741156 gene-cell line associations

Data Access

API
Script

Visualizations

  • Attribute Similarity

  • Dataset

  • Gene Similarity

cell line Gene Sets

1026 sets of genes mutated in cell lines from the COSMIC Cell Line Gene Mutation Profiles dataset.

Gene Set Description
201T cell line derived from -666
22RV1 Human prostate carcinoma cell line; derived from a human prostate carcinoma xenograft (CWR22R) that was serially propagated in nude mice after castration-induced regression and relapse of the parental, androgen-dependent CWR22 xenograft.
23132-87
42-MG-BA
451LU
5637
639-V disease: carcinoma, transitional cell
647-V
697 Human B cell precursor leukemia; established from the bone marrow of a 12-year-old boy with acute lymphoblastic leukemia (cALL) at relapse in 1979.
769-P
786-0 This line was derived from a primary clear cell adenocarcinoma. The karyotype is hypertriploid; Y was present in 60% the cells examined. The cells display both microvilli and desmosomes, and can be grown in soft agar. The cells produce a PTH like peptides that is identical to peptides produced by breast and lung tumors.
8-MG-BA
8305C Human thyroid carcinoma cell line, established from the primary tumor of a 67-year-old woman with primary thyroid undifferentiated carcinoma.
8505C Established from undifferentiated thyroid carcinomas of a 78 year old female patient.
A101D
A172 A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0183(Deposited from Tohoku Univ.).
A204
A2058 Human skin melanoma cell line, established from a 43 years adult caucasian male.
A253
A2780 Human ovarian carcinoma cell line.
A3-KAW
A375
A388
A4-FUK
A427
A431 Human epidermoid carcinoma established from the solid tumor of an 85-year-old woman; cells were reported to have large numbers of EGF binding sites; cell line was used as indicator cell line for anti-TGF binding.
A498
A549 Human lung carcinoma established from an explanted lung tumor which was removed from a 58-year-old Caucasian man in 1972; cells were described to induce tumors in athymic mice and to synthesize lecithin.
A673
A704 Human kidney adenocarcinoma cell line, established from a 78 years old male.
ABC-1
ACHN
ACN
AGS
ALL-PO
ALL-SIL Human T cell leukemia established from the peripheral blood of a 17-year-old man with T cell acute lymphoblastic leukemia, T-ALL.
AM-38
AMO-1 cell line derived from haematopoietic_and_lymphoid_tissue
AN3-CA
ARH-77 Human plasma cell leukemia cell line, established from the peripheral blood of a 33-year-old woman with IgG plasma cell leukemia; cell line is widely used as model for multiple myeloma/plasma cell leukemia, but cells are clearly EBV+ indicating that ARH-77 might be rather a normal B-lymphoblastoid cell line than a tumor cell line.
ASH-3 cell line derived from -666
ASPC-1
ATN-1 A immortal human blood cell line cell that has the characteristics: Adult T-cell leukemia. HTLV-1 pro-virus DNA(+).
AU565
BALL-1 Human acute lymphoblastoid leukemia cell line from peripheral blood.
BB30-HNC
BB49-HNC
BB65-RCC
BC-1
BC-3
BCPAP Human papillary thyroid carcinoma derived cell line.
BE-13
BE2-M17 Human caucasian neuroblastoma cell line. The cell line BE(2)-M17 was isolated from SK-N-BE(2) by limiting dilution.
BECKER
BEN Human lung carcinoma; established from the supraclavicular tumor cells-containing lymph node of a 71-year-old man with poorly differentiated carcinoma of the lung.
BFTC-905
BFTC-909 disease: carcinoma, transitional cell
BHT-101
BHY Oral squamous cell carcinoma cell line.
BICR10 cell line derived from oral cavity
BICR22 cell line derived from upper aerodigestive tract
BICR31 cell line derived from upper_aerodigestive_tract
BICR78 cell line derived from oral cavity
BL-41 Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma.
BL-70 Human Burkitt lymphoma cell line; established from the tumor tissue at relapse of a 16-year-old Caucasian boy with Burkitt lymphoma.
BONNA-12 disease: leukemia, hairy cell
BPH-1 Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens.
BT-20 Human, Caucasian, breast, carcinoma cell line. Morphology: epithelial-like; species: human, Caucasian female 74 years old; tissue: breast; tumor: carcinoma.
BT-474
BT-483
BT-549
BV-173
BXPC-3 Human pancreatic adenocarcinoma cell line, established from a 61 year old human female.
C-33-A
C-4-I
C2BBE1 The C2BBe1 (brush border expressing) cell line was cloned in 1988 from the Caco-2 cell line by limiting dilution.
C32
C3A
CA-SKI A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366(Deposited from Tohoku Univ.).
CA46
CA9-22 A immortal human gingiva-derived cell line cell that has the characteristics: Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485(Deposited from Tohoku Univ.).
CADO-ES1
CAKI-1
CAL-120 disease: adenocarcinoma, breast
CAL-12T
CAL-148 disease: adenocarcinoma, breast
CAL-27 Human tongue squamous cell carcinoma established from the poorly differentiated squamous cell carcinoma of the tongue removed from a 56-year-old man before treatment in 1982.
CAL-29 cell line derived from urinary_tract
CAL-33 Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy).
CAL-39 disease: carcinoma, squamous cell
CAL-51
CAL-54
CAL-62
CAL-72 Human osteosarcoma cell line, established from a chemotherapy-resistant tumor sample obtained from the left knee of a 10-year-old boy with anaplastic osteoblastic sarcoma (Rosen grade IIB) in 1989.
CAL-78
CAL-85-1 disease: adenocarcinoma, breast
CALU-3
CALU-6
CAMA-1
CAOV-3
CAOV-4 disease: adenocarcinoma (ovary primary)
CAPAN-1
CAPAN-2
CAR-1 Human rectal carcinoma cell line.
CAS-1
CCF-STTG1
CCK-81 cell line derived from large_intestine
CCRF-CEM
CESS
CFPAC-1 This line was derived from a pancreatic duct adenocarcinoma (liver metastasis) from a patient with cystic fibrosis.
CGTH-W-1
CHAGO-K-1
CHL-1
CHP-126 Human neuroblastoma cell line.
CHP-134 A immortal human adrenal gland-derived cell line cell that has the characteristics: N-myc gene amplification
CHP-212
CHSA0011 cell line derived from -666
CHSA0108 cell line derived from -666
CHSA8926 cell line derived from -666
CL-11 Human lung adenocarcinoma cell line.
CL-34 cell line derived from large_intestine
CL-40 cell line derived from large_intestine
CMK
CML-T1 disease: leukemia, T cell
COLO-205
COLO-320-HSR disease: colorectal adenocarcinoma
COLO-668 disease: carcinoma, oat cell
COLO-678
COLO-679
COLO-680N disease: carcinoma, squamous cell
COLO-684
COLO-741 disease: carcinoma, colon
COLO-783
COLO-792 disease: malignant melanoma
COLO-800
COLO-824
COLO-829 disease: malignant melanoma
COR-L105
COR-L23 disease: carcinoma, large cell
COR-L279 disease: carcinoma, small cell
COR-L303 cell line derived from -666
COR-L311 disease: carcinoma, small cell
COR-L32 cell line derived from -666
COR-L321 cell line derived from -666
COR-L88 disease: carcinoma, lung small cell
COR-L95 disease: carcinoma, small cell
CP50-MEL-B cell line derived from skin
CP66-MEL
CP67-MEL
CPC-N disease: carcinoma, small cell
CRO-AP2
CRO-AP3 EBV negative PEL cell line.
CS1 cell line derived from -666
CTB-1 A immortal human cell line cell that has the characteristics: Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.
CTV-1 disease: leukemia, acute myeloid
CW-2 A immortal human colon-derived cell line cell that has the characteristics: Colon carcinoma. CEA-positive, nude mouse-transplantable.
D-245MG cell line derived from central_nervous_system
D-247MG
D-263MG
D-283MED
D-336MG
D-392MG
D-423MG
D-502MG
D-542MG
D-566MG
DAN-G
DAOY The Daoy cell line was established in 1985 by P. F Jacobsen of the Royal Perth Hospital in Western Australia. The line was derived from biopsy material taken from a tumor in the posterior fossa of a 4 year old boy.
DAUDI A immortal human blood cell line cell that has the characteristics: Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011.
DB disease: large cell lymphoma
DBTRG-05MG
DEL
DETROIT562
DG-75
DIFI cell line derived from -666
DJM-1 A immortal human zone of skin-derived cell line cell that has the characteristics: Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.
DK-MG
DMS-114
DMS-273 disease: carcinoma, small cell
DMS-53
DMS-79
DND-41 cell line derived from haematopoietic_and_lymphoid_tissue
DOHH-2
DOK
DOTC2-4510
DOV13 Ovarian carcinoma cell line.
DSH1
DU-145 A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from brain metastasis of prostate carcinoma. TKG0604(Deposited from Tohoku Univ.).
DU-4475 disease: ductal carcinoma
EB-3 disease: Burkitts lymphoma
EB2 disease: Burkitts lymphoma (B lymphocyte primary)
EBC-1 A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line. TKG0481(Deposited from Tohoku Univ.).
EC-GI-10 A immortal human esophagus-derived cell line cell that has the characteristics: Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.
ECC10 A immortal human stomach-derived cell line cell that has the characteristics: Small cell gastrointestinal carcinoma with c-myc overexpression. Cell growth is slow.
ECC12 A immortal human stomach-derived cell line cell that has the characteristics: Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow.
EFM-19
EFM-192A
EFO-21 disease: cystoadenocarcinoma
EFO-27 Human ovary adenocarcinoma cell line; established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979.
EGI-1
EHEB Human chronic B cell leukemia cell line;established from the peripheral blood of a 69-year-old woman with B-CLL (chronic lymphocytic leukemia) prior treatment by EBV-transformation in 1988; cell line may represent rather a B-lymphoblastoid cell line than a bona fide B-CLL cell line.
EJM cell line derived from haematopoietic_and_lymphoid_tissue
EKVX Non-small cell lung adenocarcinoma cell line.
EM-2 disease: leukemia, chronic myeloid
EMC-BAC-1 cell line derived from -666
EMC-BAC-2 cell line derived from -666
EN
EOL-1-CELL Human eosinophilic leukaemia cell line.
EPLC-272H disease: carcinoma, epidermoid
ES-2
ES1
ES3
ES4 cell line derived from bone
ES5
ES6
ES7
ES8
ESO26 cell line derived from -666
ESO51 cell line derived from -666
ESS-1 disease: sarcoma-stromal
ETK-1
EVSA-T
EW-1
EW-11
EW-12
EW-13
EW-16
EW-18
EW-22
EW-24
EW-3
EW-7
FADU Cell line derived from squamous cell carcinoma of the hypopharynx.
FARAGE disease: non-Hodgkins lymphoma
FLO-1 Esophageal adenocarcinoma cell line.
FTC-133 Human thyroid carcinoma cell line; obtained from a lymph node metastasis of a follicular thyroid carcinoma from a 42-year-old male.
FU-OV-1
FU97
G-292_CLONE_A141B1
G-361 Homo sapiens (human); skin; malignant melanoma cell line; established from a 31 year old caucasian male.
G-401 A human cell line derived from a pediatric patient initially classified as Wilm's tumor, reclassified as deriving from a rhabdoid tumor of the kidney
G-402 A human cell line derived from some renal leiomyeloblastoma
G-MEL cell line derived from -666
GA-10 disease: Burkitts lymphoma
GAK
GAMG Human glioblastoma cell line.
GB-1 cell line derived from central nervous system
GCIY A immortal human stomach-derived cell line cell that has the characteristics: Stomach cancer (Borrmann IV). Mutin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow.
GCT A Giant Cell Tumor (GCT) cell line derived from a human fibrous histiocytoma lung metastasis
GDM-1 disease: monoblast; myelomonoblastic leukemia
GEO Human colon cancer cell line.
GI-1 A immortal human brain-derived cell line cell that has the characteristics: Human glioma separated from gliosarcoma.
GI-ME-N
GMS-10 disease: glioblastoma
GOTO Human glioblastoma cell line.
GP5D
GR-ST A immortal human blood cell line cell that has the characteristics: RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.
GRANTA-519 disease: lymphoma, B cell
GT3TKB
H-EMC-SS disease: chondrosarcoma
H2369 cell line derived from -666
H2373 cell line derived from -666
H2461 cell line derived from -666
H2591 cell line derived from -666
H2595 cell line derived from -666
H2722 cell line derived from -666
H2731 cell line derived from -666
H2795 cell line derived from -666
H2803 cell line derived from -666
H2804 cell line derived from -666
H2810 cell line derived from -666
H2818 cell line derived from -666
H2869 cell line derived from -666
H290 cell line derived from -666
H3118 cell line derived from -666
H3255
H4
H513 cell line derived from -666
H9
HA7-RCC cell line derived from kidney
HAL-01 A immortal human blood cell line cell that has the characteristics: Acute lymphatic leukemia
HARA cell line derived from lung
HC-1 disease: leukemia, hairy cell
HCC-15
HCC-33 cell line derived from lung
HCC-366
HCC-44
HCC-56 cell line derived from large_intestine
HCC-78
HCC-827
HCC1143 disease: primary ductal carcinoma
HCC1187 disease: primary ductal carcinoma
HCC1395
HCC1419 disease: primary ductal carcinoma
HCC1428 disease: adenocarcinoma (mammary gland primary)
HCC1500 disease: primary ductal carcinoma
HCC1569 disease: primary metaplastic carcinoma
HCC1599 disease: primary ductal carcinoma
HCC1806 disease: primary acantholytic squamous cell carcinoma
HCC1937
HCC1954
HCC202 disease: primary ductal carcinoma
HCC2157 disease: primary ductal carcinoma
HCC2218 disease: primary ductal carcinoma
HCC2998
HCC38
HCC70 disease: primary ductal carcinoma
HCE-4 Human esophageal carcinoma cell line.
HCT-116 Human colon colorectal carcinoma cell line from a male organism. Human colon carcinoma cell line; established from the primary colon carcinoma of an adult man.
HCT-15
HD-MY-Z
HDLM-2
HDQ-P1 cell line derived from breast
HEC-1
HEL Human erythroleukemia, established from the peripheral blood of a 30-year-old man with erythroleukemia (AML M6) in relapse (after treatment for Hodgkin's disease) in 1980; cells were described to be capable of spontaneous and induced globin synthesis.
HELA Human cervix carcinoma established from the epitheloid cervix carcinoma of a 31-year-old black woman in 1951. Later diagnosis changed to adenocarcinoma, first aneuploid, continuously cultured human cell line.
HEP_3B2_1-7 disease: hepatocellular carcinoma
HEY Human ovarian carcinoma cell line.
HGC-27 This human gastric carcinoma cell line was established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histological as undifferentiated carcinoma.
HH
HL-60 Human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976.
HLE Human lens epithelial cell line.
HMV-II A immortal human cell line cell that has the characteristics: Melanin producing. Originated from the same site of HMV-I.
HN Oral squamous cell carcinoma cell line.
HO-1-N-1
HO-1-U-1 A immortal human mouth-derived cell line cell that has the characteristics: Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455(Deposited from Tohoku Univ.).
HOP-62 Non-small cell lung adenocarcinoma cell line.
HOP-92 Non-small cell lung adenocarcinoma cell line.
HOS
HPAC
HPAF-II
HS-445 disease: lymphoma; Hodgkins disease
HS-578-T
HS633T
HS683 Human brain glioma cell line. Hs 683 was isolated from explant cultures of a glioma taken from the left temporal lobe of a 76 year old male Caucasian.
HS746T disease: gastric carcinoma (stomach primary
HS766T Human pancreatic cancer cell line.
HS939-T
HS940-T disease: malignant melanoma
HSC-2 A immortal human mouth-derived cell line cell that has the characteristics: Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).
HSC-3 A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484(Deposited from Tohoku Univ.).
HSC-39 cell line derived from -666
HSC-4 A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).
HT disease: diffuse mixed lymphoma; B lymphoblast
HT-1080
HT-115 Human colon carcinoma cell line.
HT-1197
HT-1376
HT-144 Homo sapiens (human), morphology: fibroblast, tissue: metastatic site: subcutaneous tissue malignant melanoma, established from a 29-year-old caucasian men.
HT-29
HT-3 disease: carcinoma (cervix primary)
HT55
HTC-C3 A immortal human thyroid gland-derived cell line cell that has the characteristics: Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin
HUCCT1 A immortal human cell line cell that has the characteristics: Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389(Deposited from Tohoku Univ.).
HUH-1 cell line derived from liver
HUH-6-CLONE5 cell line derived from liver
HUH-7 HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers.
HUO-3N1 A immortal human cell line cell that has the characteristics: Human cell line derived from osteosarcoma. TKG0452(Deposited from Tohoku Univ.).
HUO9
HUP-T3
HUP-T4
HUTU-80
IA-LM A immortal human cell line cell that has the characteristics: Japanese lung large cell carcinoma
IGR-1
IGR-37
IGROV-1
IHH-4 cell line derived from -666
IM-9 Human B lymphoblastoid cell line (from patient with multiple myeloma); established from the bone marrow of a woman with multiple myeloma in 1967. Although derived from the blood of a patient with multiple myeloma, this line has been shown to be an EBV-transformed B lymphoblastoid cell line.
IM-95 cell line derived from stomach
IMR-5
IPC-298
ISHIKAWA(HERAKLIO)02ER-
IST-MEL1
IST-MES1 disease: mesothelioma
IST-SL1 disease: carcinoma, small cell
IST-SL2 disease: carcinoma, small cell
J82
JAR
JEG-3
JEKO-1
JHH-1 cell line derived from liver
JHH-2 cell line derived from liver
JHH-4 cell line derived from liver
JHH-6 cell line derived from liver
JHH-7 cell line derived from liver
JHOS-2 A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Ovary serous adenocarcinoma. Said CA125, CA15-3 producing.
JHOS-3 A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow.
JHOS-4 A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow.
JHU-011 Human head and neck squamous cell carcinoma (HNSCC) cell line.
JHU-022 Human head and neck squamous cell carcinoma (HNSCC) cell line.
JHU-029 Human head and neck squamous cell carcinoma (HNSCC) cell line.
JIMT-1
JIYOYEP-2003
JJN-3 cell line derived from haematopoietic_and_lymphoid_tissue
JM1 disease: leukemia; lymphoma
JSC-1 disease: B cell lymphoma (metastatic site: peritoneal cavity)
JURKAT Human T cell leukemia, established from the peripheral blood of a 14-year-old boy with acute lymphoblastic leukemia (ALL) at first relapse in 1976; often this cell line is called JM (JURKAT and JM are derived from the same patient and are sister clones), occasionally JM may be a subclone with somewhat divergent features.
JURL-MK1 cell line derived from haematopoietic and lymphoid tissue
JVM-2 disease: leukemia, chronic, B cell
JVM-3 disease: leukemia, chronic, B cell
K-562 Human chronic myeloid leukemia in blast crisis established from the pleural effusion of a 53-year-old woman with chronic myeloid leukemia (CML) in blast crisis in 1970.
K2 cell line derived from -666
K5
KALS-1
KARPAS-1106P cell line derived from lymph node
KARPAS-231
KARPAS-299
KARPAS-422 Human B cell lymphoma cell line; established from the pleural effusion of a 73-year-old woman with B cell non-Hodgkin lymphoma (intraabdominal, diffuse large cell lymphoma, refractory, terminal) in 1987.
KARPAS-45 disease: leukemia, T cell
KARPAS-620 cell line derived from haematopoietic_and_lymphoid_tissue
KASUMI-1 Human acute myelocytic leukemia cell line; derived from the peripheral blood of a 7-year-old japanese boy with acute myelocytic leukemia in relapse after bone marrow transplantation.
KATOIII
KCL-22 A Philadelphia chromosome-positive cell line established from peripheral blood of a patient with chronic myelogenous leukemia in blast crisis.
KE-37 Human T cell leukemia cell line; established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979.
KELLY
KG-1 A immortal human bone marrow-derived cell line cell that has the characteristics: Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+
KGN A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.
KINGS-1
KLE
KM-H2 Human Hodgkin lymphoma cell line, established from the pleural effusion of a 37-year-old man with Hodgkin lymphoma (mixed cellularity progressing to lymphocyte depletion; stage IV at relapse) in 1974.
KM12 Human colon carcinoma cell line.
KMH-2 Human Hodgkin lymphoma cell line, established from the pleural effusion of a 37-year-old man with Hodgkin lymphoma (mixed cellularity progressing to lymphocyte depletion; stage IV at relapse) in 1974.
KMOE-2 disease: erythremia acute
KMRC-1 cell line derived from kidney
KMRC-20 cell line derived from kidney
KMS-11 KMS-11 cell line was derived from four patients with multiple myeloma. These cells represent a later stage of B-cell differentiation, and shows characteristics of plasma cells by secreting surface kappa chain immunoglobulins.
KMS-12-BM cell line derived from haematopoietic_and_lymphoid_tissue
KNS-42
KNS-62
KNS-81-FD
KO52 cell line derived from haematopoietic_and_lymphoid_tissue
KON cell line derived from -666
KOPN-8 cell line derived from haematopoietic_and_lymphoid_tissue
KOSC-2
KP-1N Human pancreatic cancer cell line, obtained from liver metastases of pancreatic tumors.
KP-2 Human pancreatic cancer cell line of primary pancreatic origin.
KP-3 Human pancreatic cancer cell line, obtained from liver metastases of pancreatic tumors.
KP-4 A immortal human cell line cell that has the characteristics: Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.
KP-N-RT-BM-1
KP-N-YN Human neuroblastoma cell line.
KP-N-YS
KS-1
KU-19-19 disease: carcinoma, transitional cell
KU812 A immortal human blood cell line cell that has the characteristics: Chronic myelogeneous leukemia, Ph1 chromosome (+),basophi-like cells.
KURAMOCHI
KY821
KYAE-1 cell line derived from -666
KYM-1 cell line derived from soft_tissue
KYSE-140 disease: carcinoma, squamous cell
KYSE-150 Human esophageal squamous cell carcinoma cell line; established from the poorly differentiated esophageal squamous cell carcinoma resected from upper (cervical) esophagus of a 49-year-old Japanese woman after receiving radiotherapy.
KYSE-180 disease: carcinoma, squamous cell
KYSE-220 cell line derived from -666
KYSE-270 disease: carcinoma, squamous cell
KYSE-30
KYSE-410 disease: carcinoma, squamous cell
KYSE-450 disease: carcinoma, squamous cell
KYSE-50 cell line derived from -666
KYSE-510 disease: carcinoma, squamous cell
KYSE-520 disease: carcinoma, squamous cell
KYSE-70 disease: carcinoma, squamous cell
L-1236 cell line derived from haematopoietic_and_lymphoid_tissue
L-363 Multiple myeloma cell line expressing syndecan-1.
L-428
L-540
LAMA-84 Human chronic myeloid leukemia in blast crisis; established from the peripheral blood of a 29-year-old woman with chronic myeloid leukemia.
LAN-6
LB1047-RCC
LB2241-RCC
LB2518-MEL
LB373-MEL-D
LB647-SCLC
LB771-HNC
LB831-BLC
LB996-RCC
LC-1-SQ A immortal human cell line cell that has the characteristics: Parent cell line of LC/sq-SFthe same patient as RCB0439 LC-F. Cell growth is slow.
LC-2-AD A immortal human cell line cell that has the characteristics: Adenocarcinoma, moderately diffirentiated. Cell growth is slow.
LC4-1 B-precursor acute lymphoblastic leukemia cell line.
LCLC-103H disease: carcinoma, large cell
LCLC-97TM1 disease: carcinoma, large cell
LIM1215 Colonic cancer cell line.
LK-2 A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line.TKG0494 (Deposited from Tohoku Univ.).
LN-18 Human brain, cerebrum; right temporal lobe, glioblastoma; glioma; grade IV cell line; established from a 65 years old white male.
LN-229 Human brain, right frontal parieto-occipital cortex, glioblastoma cell line; established from a 60 years old white female.
LN-405
LNCAP-CLONE-FGC disease: carcinoma (prostate primary)
LNZTA3WT4 disease: glioblastoma; p53 expression under tetracycline-induced promoter
LOU-NH91 disease: carcinoma, squamous cell
LOUCY disease: T lymphocyte; acute lympho- blastic leukemia; t(16;20) translocation
LOVO A immortal human colon-derived cell line cell that has the characteristics: CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow.
LOXIMVI Human melanoma cell line.
LP-1
LS-1034 disease: colorectal carcinoma
LS-123
LS-180 Human, Caucasian, colon, adenocarcinoma, colorectal, cell line. Morphology: epithelial; Species: human, Caucasian female 58 year old; Tissue: colon; Tumor: adenocarcinoma, colorectal.
LS-411N disease: colorectal carcinoma
LS-513 disease: colorectal carcinoma
LU-134-A A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type. See Lu-134-B.
LU-135 A immortal human cell line cell that has the characteristics: Small cell carcinoma, variant type
LU-139 A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type
LU-165 A immortal human cell line cell that has the characteristics: Producing high level of anti-diuretic hormone.
LU-65 A immortal human cell line cell that has the characteristics: Human lung carcinoma cell line. TKG0442(Deposited from Tohoku Univ.).
LU-99A
LXF-289
M059J disease: malignant glioblastoma; glioma
M14 The human melanoma cell line M14 has been established from surgically removed melanoma metastases.
MC-1010 cell line derived from haematopoietic_and_lymphoid_tissue
MC-CAR disease: hybridoma fusion partner
MC-IXC
MC116
MCAS cell line derived from ovary
MCC13 cell line derived from -666
MCC26 cell line derived from -666
MCF7 A immortal human breast-derived cell line cell that has the characteristics: Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).
MDA-MB-157 disease: carcinoma (mammary gland primary)
MDA-MB-175-VII
MDA-MB-231
MDA-MB-330 disease: carcinoma (mammary gland primary)
MDA-MB-361
MDA-MB-415 disease: adenocarcinoma (mammary gland primary)
MDA-MB-436
MDA-MB-453
MDA-MB-468
MDST8 cell line derived from large_intestine
ME-1 disease: hybridoma
ME-180 disease: epidermoid carcinoma (cervix primary)
MEG-01
MEL-HO Human melanoma; established from the primary tumor of a woman with melanoma in 1976; cells express mRNA of the oncogene c-myc.
MEL-JUSO Human melanoma, established from the primary tumor of a 58-year-old woman with melanoma in 1977.
MES-SA disease: uterine sarcoma
MEWO Human skin malignant melanoma cell line.
MFE-280
MFE-296
MFE-319
MFH-INO A immortal human cell line cell that has the characteristics: Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features.
MFM-223 Human breast carcinoma; established from the pleural effusion of a post-menopausal breast cancer patient without any prior treatment (tumor: widespread ductal mammary carcinoma T4 N2 M1 with histological grade III); cells were described to express androgen, estrogen and progesterone receptors.
MG-63
MHH-CALL-2 disease: leukemia, pre-B cell
MHH-CALL-4 disease: leukemia, pre-B cell
MHH-ES-1
MHH-NB-11
MHH-PREB-1
MIA-PACA-2 A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0227(Deposited from Tohoku Univ.)
MKN1 A immortal human stomach-derived cell line cell that has the characteristics: Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.
MKN28 Well differentiated human gastric adenocarcinoma cell line.
MKN45 Human gastric adenocarcinoma, established from the poorly differentiated adenocarcinoma of the stomach (medullary type) of a 62-year-old woman.
MKN7 A immortal human stomach-derived cell line cell that has the characteristics: c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.
ML-1 Human acute myeloblastic leukaemia cell line from human peripheral blood. Morphology: Myoblast.
ML-2
MLMA cell line derived from haematopoietic_and_lymphoid_tissue
MM1S Human B lymphoblast multiple myeloma cell line.
MMAC-SF
MN-60 disease: leukemia, B cell
MO-T
MOG-G-CCM disease: astrocytoma, anaplastic
MOG-G-UVW disease: astrocytoma, anaplastic
MOLM-13 Human acute myeloid leukemia cell line; established from the peripheral blood of a 20-year-old man with acute myeloid leukemia AML FAB M5a at relapse in 1995 after initial myelodysplastic syndromes.
MOLM-16 Human acute myeloid leukemia cell line; established in 1999 from the peripheral blood of a 77-year-old Japanese woman at relapse of acute myeloid leukemia (AML M0) after failed chemotherapy.
MOLP-8 cell line derived from haematopoietic_and_lymphoid_tissue
MOLT-13 Human T cell leukemia cell line; established from the bone marrow of a 2-year-old girl with T-ALL (T cell acute lymphoblastic leukemia, FAB L2) at relapse in 1983.
MOLT-16
MOLT-4
MONO-MAC-6 Human acute monocytic leukemia cell line; established from the peripheral blood of a 64-year-old man with relapsed acute monocytic leukemia (AML FAB M5) in 1985 following myeloid metaplasia. Sister cell line of MONO-MAC-1.
MPP-89 disease: mesothelioma
MRK-NU-1 Human mammary gland carcinoma cell line, established from a 46 years old female.
MS-1
MS751 disease: epidermoid carcinoma (cervix primary)
MSTO-211H Human mesothelioma cell line; established from the pleural effusion of a 62-year-old Caucasian man with mesothelioma (malignant biphasic) who did not have any prior therapy.
MV-4-11 Human acute myelocytic leukemia cell line.
MY-M12 cell line derived from -666
MZ1-PC cell line derived from pancreas
MZ2-MEL
MZ7-MEL
NALM-6
NAMALWA
NB(TU)1-10 cell line derived from -666
NB-4
NB1 A immortal human adrenal gland-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486(Deposited from Tohoku Univ.).
NB10
NB12
NB13
NB14 Human neuroblastoma tumor cell line.
NB17
NB5 Human neuroblastoma tumor cell line.
NB6
NB69 A immortal somatic nervous system-derived cell line cell that has the characteristics: N-myc gene unamplified tumor. Cell growth is slow.
NB7 Human neuroblastoma cell line.
NBSUSSR A immortal human cell line cell that has the characteristics: Isolated from a patient with hiper dopaminemia andnorepinephrinemia.
NCC010 cell line derived from -666
NCC021 cell line derived from -666
NCCIT Human pluripotent embryonal carcinoma, teratocarcinoma cell line; established in 1985 from a mediastinal mixed germ cell tumor of an adult Japanese male. This pluripotent stem cell line is capable of somatic and extraembryonic differentiation.
NCI-H1048 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H1092 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H1105 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H1155
NCI-H128 Small cell lung cancer cell line.
NCI-H1299
NCI-H1304 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H1341 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H1355
NCI-H1395
NCI-H1417 disease: carcinoma; classic small cell lung cancer
NCI-H1435 Non-small cell lung cancer cell line.
NCI-H1436 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H1437
NCI-H146 Small cell lung cancer cell line.
NCI-H1563 disease: adenocarcinoma; non-small cell lung cancer
NCI-H1568 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H1573 disease: adenocarcinoma (lung primary)
NCI-H1581 disease: large cell adenocarcinoma; non-small cell lung cancer
NCI-H1623 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H1648 disease: adenocarcinoma (lung primary)
NCI-H1650
NCI-H1651 disease: adenocarcinoma; non-small cell lung cancer
NCI-H1666 disease: adenocarcinoma; bronchoalveolar carcinoma (lung primary)
NCI-H1688 disease: carcinoma; classic small cell lung cancer
NCI-H1693 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H1694 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H1703
NCI-H1734 disease: adenocarcinoma; non-small cell lung cancer
NCI-H1755 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H1770 disease: neuroendocrine carc- cinoma; non-small cell lung cancer (lung primary)
NCI-H1781 disease: adenocarcinoma; bronchoalveolar carcinoma (lung primary)
NCI-H1792 disease: adenocarcinoma (lung primary)
NCI-H1793 disease: adenocarcinoma; non-small cell lung cancer
NCI-H1836 disease: carcinoma; classic small cell lung cancer
NCI-H1838 disease: adenocarcinoma; non-small cell lung cancer
NCI-H1869 disease: squamous cell carcinoma (lung primary)
NCI-H187
NCI-H1876 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H1915 Human non-small cell lung cancer cell line.
NCI-H1944 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H196 Small cell lung cancer cell line.
NCI-H1963 disease: carcinoma; small cell lung cancer
NCI-H1975
NCI-H1993 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H2009
NCI-H2023 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H2029 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H2030 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H2052 disease: mesothelioma (pleura primary)
NCI-H2066 disease: small cell lung cancer; adenocar- cinoma; squamous cell carcinoma
NCI-H2081 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H2085 disease: adenocarcinoma; non-small cell lung cancer
NCI-H2087
NCI-H209 Small cell lung cancer cell line.
NCI-H211 Human small cell lung cancer cell line.
NCI-H2110 disease: non-small cell lung cancer (lung primary)
NCI-H2122
NCI-H2126
NCI-H2135 disease: non-small cell lung cancer
NCI-H2141 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H2170
NCI-H2171 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H2172 disease: non-small cell lung cancer
NCI-H2196 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H2227 disease: carcinoma; small cell lung cancer
NCI-H2228 disease: adenocarcinoma; non-small cell lung cancer
NCI-H226
NCI-H2291 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H23
NCI-H2342 disease: adenocarcinoma; non-small cell lung cancer
NCI-H2347
NCI-H2405 disease: adenocarcinoma; non-small cell lung cancer (lung primary)
NCI-H2444 disease: non-small cell lung cancer
NCI-H2452 disease: mesothelioma
NCI-H250 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H28 disease: mesothelioma (pleura primary)
NCI-H292 Mucoepidermoid human lung carcinoma cell line; established from a black female 32 years old; Morphology: epithelial.
NCI-H3122 cell line derived from lung
NCI-H322M Human non-small cell lung cancer cell line.
NCI-H345 Small cell lung cancer cell line.
NCI-H358
NCI-H378 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H441
NCI-H446 disease: carcinoma; small cell lung cancer (lung primary)
NCI-H460
NCI-H508 disease: colorectal adenocarcinoma
NCI-H510A disease: carcinoma; small cell lung cancer (unknown primary)
NCI-H520
NCI-H522
NCI-H524
NCI-H526 Human small cell lung cancer cell line; established from a 55 years old caucasian male.
NCI-H596 Human lung adenosquamous carcinoma cell line; derived in 1983 from a tumor mass in the chest wall of a patient with adenosquamous carcinoma of the lung.
NCI-H630 disease: carcinoma (rectum primary)
NCI-H64
NCI-H647 Human non-small cell lung adenosquamous carcinoma cell line, established from a 56 years old caucasian male.
NCI-H650 disease: bronchioalveolar carci- noma; non-small cell lung cancer (lung primary)
NCI-H660 Homo sapiens (human) lung; small cell lung cancer cell line, extrapulmonary origin; established from a 63 years adult caucasian male. Morphology: epithelial; cell type: neuroendocrine; Tumor stage E; derived from metastatic site: lymph node.
NCI-H661
NCI-H69 Human Caucasian lung small cell carcinoma cell line.
NCI-H716
NCI-H720 disease: atypical carcinoid
NCI-H727 disease: carcinoid
NCI-H740 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H747 disease: colorectal adenocarcinoma
NCI-H748 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H810 disease: large cell; neuroendocrine; carcinoma; non-small cell lung cancer
NCI-H82
NCI-H820 disease: papillary adenocarci- noma (lung primary)
NCI-H835 disease: carcinoid
NCI-H838
NCI-H841 disease: carcinoma; variant small cell lung cancer (lung primary)
NCI-H847 disease: carcinoma; classic small cell lung cancer (lung primary)
NCI-H929 Human multiple myeloma cell line; established from the pleural effusion of a 62-year-old white woman with myeloma (IgAkappa) at relapse.
NCI-N87
NCI-SNU-1
NCI-SNU-16
NCI-SNU-5
NEC8 A immortal human testis-derived cell line cell that has the characteristics: Embryonal carcinoma, testis.
NH-12 A immortal somatic nervous system-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma. TKG0448(Deposited from Tohoku Univ.).
NK-92MI disease: IL-2 independent, cytotoxic to a wide range of malignant cells
NKM-1
NMC-G1
NO-10
NO-11
NOMO-1
NOS-1 A immortal human bone element-derived cell line cell that has the characteristics: Osteoid producing in vitro and in nude mice. Cell growth is slow.
NTERA-2_CL_D1 Testis; metastatic site: lung malignant pluripotent embryonal carcinoma cell line. The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line.
NU-DUL-1 cell line derived from haematopoietic_and_lymphoid_tissue
NUGC-3 Human gastric adenocarcinoma cell line established from a 72-year-old male.
NUGC-4 A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).
NY
OACM5-1 cell line derived from -666
OACP4C cell line derived from -666
OAW-28
OAW-42 disease: cystoadenocarcinoma
OC-314 disease: cystoadenocarcinoma, low differentiated, papillary serous; G2/3 FIGO stage III c
OCI-AML2 Human acute myeloid leukemia cell line; established from the peripheral blood of a 65-year-old man with acute myeloid leukemia.
OCI-AML3 Human acute myeloid leukemia cell line; established from the peripheral blood of a 57-year-old man with acute myeloid leukemia.
OCI-AML5 Human acute myeloid leukemia cell line; established from the peripheral blood of a 77-year-old man with acute myeloid leukemia.
OCI-LY-19 cell line derived from haematopoietic_and_lymphoid_tissue
OCI-LY7
OCI-M1 Human acute myeloid leukemia cell line; established from erythroleukemia blasts, AML M6, of a 62-year-old patient following a 7-year chlorambucil treatment for chronic lymphocytic leukemia.
OCUB-M A immortal human mammary gland-derived cell line cell that has the characteristics: Same as OCUB-1, OCUB-F. Chromosome = pseudotetraploid.
OCUM-1 cell line derived from stomach
OE19
OE21
OE33
OMC-1 A immortal human uterine cervix-derived cell line cell that has the characteristics: Japanese cervix squamous cell carcinoma. Once said TA-4 positive.
ONS-76
OPM-2
OS-RC-2 A immortal human kidney-derived cell line cell that has the characteristics: Renal tumor cell from a Japanese. Transplantable to nude mice.
OSC-19 cell line derived from -666
OSC-20 cell line derived from -666
OUMS-23 cell line derived from large_intestine
OV-17R cell line derived from ovary
OV-56 cell line derived from ovary
OV-7 cell line derived from ovary
OV-90
OVCA420 Human epithelial ovarian cancer cell line.
OVCA433 Human epithelial ovarian cancer cell line.
OVCAR-3
OVCAR-4
OVCAR-5
OVCAR-8
OVISE Human ovarian carcinoma cell line from clear cell adenocarcinoma.
OVK-18 A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).
OVKATE Human ovarian carcinoma cell line from serous papillary adenocarcinoma.
OVMIU cell line derived from -666
OVTOKO Human ovarian carcinoma cell line from clear cell adenocarcinoma.
P12-ICHIKAWA Human T cell leukemia; established from the peripheral blood of a 7-year-old boy with acute lymphoblastic leukemia (ALL).
P30-OHK A immortal human blood cell line cell that has the characteristics: Human cell line derived from T cell leukemia. TKG0463(Deposited from Tohoku Univ.).
P31-FUJ
P32-ISH cell line derived from -666
PA-1 Human ovary ascites teratocarcinoma cell line. The line was established from cells taken from ascitic fluid.
PA-TU-8902
PA-TU-8988T
PANC-02-03
PANC-03-27
PANC-04-03
PANC-08-13
PANC-10-05 disease: adenocarcinoma; same patient as PL45
PC-14
PC-3
PC-3_[JPC-3] cell line derived from -666
PCI-15A cell line derived from -666
PCI-30 cell line derived from -666
PCI-38 cell line derived from -666
PCI-4B cell line derived from -666
PCI-6A cell line derived from -666
PE/CA-PJ15 cell line derived from upper_aerodigestive_tract
PEO1
PF-382
PFSK-1 disease: malignant primitive neuroectodermal tumor
PL-21 cell line derived from haematopoietic_and_lymphoid_tissue
PL18 cell line derived from -666
PL4 cell line derived from -666
PSN1 Human pancreatic adenocarcinoma cell line.
PWR-1E Human prostatic epithelial cells, derived from a normal prostate with mild hyperplasia, were immortalized with an adenovirus 12-SV40 hybrid virus (Ad12-SV40). PWR-1E cell line was derived by single cell cloning of a non-producer cell.
QGP-1 Human pancreatic neuroendocrine tumor cell line.
QIMR-WIL disease: leukemia, myeloblastic
RAJI
RAMOS-2G6-4C10 disease: Burkitts lymphoma (American)
RC-K8 cell line derived from blood
RCC-AB cell line derived from kidney
RCC-ER cell line derived from kidney
RCC-FG2 cell line derived from kidney
RCC-JF cell line derived from kidney
RCC-JW cell line derived from kidney
RCC-MF cell line derived from kidney
RCC10RGB A immortal human kidney-derived cell line cell that has the characteristics: Kidney carcinoma from a Japanese patient. Cell growth is slow.
RCH-ACV
RCM-1
RD
REH Human B cell precursor leukemia established from the peripheral blood of a 15-year-old North African girl with acute lymphoblastic leukaemia, ALL at first relapse, in 1973.
RERF-GC-1B cell line derived from stomach
RERF-LC-FM cell line derived from lung
RERF-LC-KJ A immortal human cell line cell that has the characteristics: Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow.
RERF-LC-MS
RERF-LC-SQ1 cell line derived from lung
RF-48 cell line derived from stomach
RH-1 Human rhabdomyosarcoma cell line.
RH-18 Human rhabdomyosarcoma cell line.
RH-41 cell line derived from soft_tissue
RKN cell line derived from soft_tissue
RKO
RL
RL95-2
RMG-I Human tumor cell line from ovarian mesonephroid adenocarcinoma.
RO82-W-1
ROS-50 cell line derived from -666
RPMI-2650 Human nasal septum squamous cell carinoma cell line; established from the pleural effusion of a 52-year-old man with anaplastic squamous cell carcinoma of the nasal septum in 1962.
RPMI-6666 disease: Hodgkins disease
RPMI-7951 Human skin malignant melanoma cells that can be ordered from ATCC. This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high. Cells are adherent, and were first harvested in 1971 from a metastatic site in a lymph node.
RPMI-8226
RPMI-8402 Human T cell acute lymphoblastic leukemia cell line; established from the peripheral blood of a 16-year-old woman with acute lymphoblastic leukemia (ALL) in 1972.
RPMI-8866 Human B lymphoid cell line, established from the peripheral blood of a 51-year-old American woman with chronic myelogenous leukemia in May 1966.
RS4-11 Human B cell precursor leukemia cell line; established from the bone marrow of a 32-year-old woman with acute lymphoblastic leukemia (ALL L2) in first relapse.
RT-112 Human urinary bladder transitional cell carcinoma established from the transitional cell carcinoma histological grade G2 excised from a female patient with untreated primary urinary bladder carcinoma in 1973.
RT4 Human urinary bladder transitional cell carcinoma; established from a recurrent well-differentiated transitional papillary tumor of the urinary bladder (clinical stage T2, histological grade G1, treated with gold grains 2 years earlier and diathermy after recurrence 10 months later) of a 63-year-old man in 1968.
RVH-421
RXF393 Renal cancer cell line.
S-117
SAOS-2 Human osteogenic sarcoma, established from the primary osteogenic sarcoma of an 11-year-old Caucasian woman in 1973.
SARC9371 cell line derived from -666
SAS A immortal human tongue-derived cell line cell that has the characteristics: Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470(Deposited from Tohoku Univ.).
SAT cell line derived from -666
SBC-1 Human small cell lung cancer cell line.
SBC-3 cell line derived from lung
SBC-5
SC-1 A immortal mouse embryo-derived cell line cell that has the characteristics: Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses.
SCABER
SCC-15 Human tongue squamous cell carcinoma cell line.
SCC-25 Human squamous cell carcinoma cell line; established from the biopsy of a squamous cell carcinoma of the tongue of a 70-year-old man.
SCC-3
SCC-4 Human squamous cell carcinoma cell line; established from the squamous cell carcinoma of the tongue from a 55-year-old man after radio- and chemotherapy in 1980.
SCC-9 disease: squamous cell carcinoma
SCC90 cell line derived from -666
SCH
SET2 Acute myeloid leukemia cell line. Human essential thrombocythemia cell line; established from the peripheral blood of a 71-year-old woman with essential thrombocythemia at megakaryoblastic leukemic transformation.
SF126
SF268
SF295
SF539
SH-4
SHP-77
SIG-M5 disease: leukemia, acute monocytic
SIHA
SIMA
SISO
SJRH30 disease: rhabdomyosarcoma (muscle primary)
SJSA-1
SK-CO-1 disease: colorectal adenocarcinoma (colon primary)
SK-ES-1 disease: sarcoma (anaplastic osteosarcoma or Ewings sarcoma)
SK-GT-2 cell line derived from -666
SK-GT-4
SK-HEP-1 Human liver adenocarcinoma cell line; established from the ascites of a 52-year-old Caucasian man in 1971.
SK-LMS-1
SK-LU-1 Non-small cell lung cancer cell line.
SK-MEL-1
SK-MEL-2
SK-MEL-24 disease: malignant melanoma
SK-MEL-28
SK-MEL-3
SK-MEL-30 Human melanoma derived from tumor tissue (subcutis metastasis) of a 67-year-old Caucasian man with malignant melanoma in 1975.
SK-MEL-31 disease: malignant melanoma
SK-MEL-5 Human caucasian skin melanoma cell line; established from a 24 year old Caucasian female. Derived from: axillary node.
SK-MES-1
SK-MG-1
SK-MM-2
SK-N-AS
SK-N-DZ Neuroblastoma cell line derived in 1978 from a bone marrow metastasis from a 2 years old caucasian female child with poorly differentiated embryonal neuroblastoma.
SK-N-FI Neuroblastoma cell line; derived in 1979 from a bone marrow metastasis from a 11 year old Caucasian male with poorly differentiated embryonal neuroblastoma.
SK-N-SH
SK-NEP-1 disease: Wilmstumor (kidney primary)
SK-OV-3
SK-PN-DW disease: retroperitoneal; malignant; primitive neuroectodermal tumor
SK-UT-1
SKG-IIIA A immortal human uterine cervix-derived cell line cell that has the characteristics: Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/.TKG0462(Deposited from Tohoku Univ.).
SKM-1
SKN A immortal human endometrium-derived cell line cell that has the characteristics: Estradiol-17 beta responsive leiomyosarcoma
SKN-3 cell line derived from -666
SLVL A immortal human spleen-derived cell line cell that has the characteristics: Human cell line derived from splenic B cell lymphoma.
SN12C Human renal cell carcinoma cell line.
SNB75 Human glioblastoma cell line.
SNG-M
SNU-1040 cell line derived from large_intestine
SNU-175 cell line derived from large_intestine
SNU-182
SNU-283 cell line derived from large_intestine
SNU-387
SNU-398
SNU-407 cell line derived from large_intestine
SNU-423
SNU-449
SNU-475
SNU-61 cell line derived from large intestine
SNU-81 cell line derived from large_intestine
SNU-C1 disease: adenocarcinoma colon primary)
SNU-C2B disease: colorectal carcinoma
SNU-C5 cell line derived from large_intestine
SR
ST486 disease: Burkitts lymphoma
STS-0421 cell line derived from -666
SU-DHL-1
SU-DHL-10
SU-DHL-16
SU-DHL-4 cell line derived from haematopoietic_and_lymphoid_tissue
SU-DHL-5
SU-DHL-6
SU-DHL-8 cell line derived from haematopoietic_and_lymphoid_tissue
SU8686 Homo sapiens (human) pancreatic adenocarcinoma cell line. The line was developed from a wedge biosy of a liver metastasis of a pancreatic ductal carcinoma.
SUIT-2 Human pancreatic cancer cell line.
SUP-B15 disease: acute lymphoblastic leukemia
SUP-B8 cell line derived from haematopoietic_and_lymphoid_tissue
SUP-HD1 cell line derived from haematopoietic_and_lymphoid_tissue
SUP-M2 Human anaplastic large cell lymphoma (ALCL) cell line; derived from the cerebrospinal fluid of a 5-year-old girl with refractory malignant histiocytosis.
SUP-T1 Human T cell lymphoma cell line; established from the pleural effusion of an 8-year-old boy with T-lymphoblastic lymphoma in relapse.
SW1088
SW1116
SW1271 disease: carcinoma; small cell lung cancer
SW13
SW1417
SW1463
SW156 disease: hypernephroma
SW1573
SW1710 disease: carcinoma, transitional cell
SW1783 disease: astrocytoma
SW1990
SW403
SW48
SW620
SW626 Human, ovary, adenocarcinoma cell line.
SW684 disease: fibrosarcoma
SW756 disease: squamous cell carcinoma
SW780 disease: transitional cell carcinoma
SW837
SW872
SW900
SW948
SW954 disease: squamous cell carcinoma
SW962 disease: carcinoma (vulva primary)
SW982 disease: synovial sarcoma
T-24
T-T
T47D
T84
T98G A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471(Deposited from Tohoku Univ.).
TALL-1 A immortal human bone marrow-derived cell line cell that has the characteristics: Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).
TASK1 cell line derived from -666
TC-71
TC-YIK A immortal human uterine cervix-derived cell line cell that has the characteristics: Integrating HPV16, neurosecretory granules(+)
TCCSUP disease: transitional cell carcinoma
TE-1 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0462(Deposited from Tohoku Univ.).
TE-10 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261(Deposited from Tohoku Univ.).
TE-11 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262(Deposited from Tohoku Univ.).
TE-12
TE-15 Human esophageal squamous cell carcinoma cell line.
TE-4 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma.TKG0255(Deposited from Tohoku Univ.).
TE-441-T disease: rhabdomyosarcoma
TE-5 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).
TE-6 A immortal human esophagus-derived cell line cell that has the characteristics: Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse.  A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cyclin and MC210. TKG0257 (Deposited from Tohoku Univ.).
TE-8 A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259(Deposited from Tohoku Univ.).
TE-9 A immortal human esophagus-derived cell line cell that has the characteristics: Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).
TGBC11TKB A immortal human stomach-derived cell line cell that has the characteristics: Japanese gastric cancer, lymph node metastated.
TGBC1TKB A immortal human cell line cell that has the characteristics: Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Cell growth is slow.
TGBC24TKB A immortal human cell line cell that has the characteristics: Japanese gallbladder carcinoma established from metastated ascite. Cell growth is slow.
TGW
THP-1
TK cell line derived from blood
TK10 TK-10 was derived from a specimen of primary RCC obtained following a left radical nephrectomy in a 43-year-old male on August 21, 1980.
TMK-1
TOV-112D TOV-112D is a human epithelial cell line initiated in October of 1992 from a patient with early onset ovarian cancer. The patient was of French-Canadian descent with an unknown family history of ovarian cancer.
TOV-21G This cell line was initiated in October of 1991 from a patient of French-Canadian descent with no family history of ovarian cancer.
TT
TT2609-C02 cell line derived from thyroid
TUR disease: histiocytic lymphoma; neomycin resistant
TYK-NU
U-118-MG Human neuronal glioblastoma (grade III) cell line.
U-2-OS
U-266 Human multiple myeloma cell line; established from the peripheral blood of a 53-year-old man with IgE-secreting myeloma (refractory, terminal) in 1968.
U-698-M disease: lymphoma, B cell
U-87-MG Human, Caucasian, brain, glioblastoma-astrocytoma cell line Morphology: epithelial-like; Species: human, Caucasian female 44 years old; Tissue: brain; Tumor: glioblastoma-astrocytoma.
U-CH2 cell line derived from bone
U031
U251 Human glioma cell line. Morphology: glial; Species: human; Tumor: glioma.
UACC-257
UACC-62
UACC-812 disease: ductal carcinoma
UACC-893
UDSCC2 cell line derived from -666
UM-UC-3
UMC-11 disease: carcinoid
UWB1_289 cell line derived from ovary
VA-ES-BJ disease: carcinoma, epithelioid (bone primary)
VAL
VCAP Human prostate cancer cell line.
VM-CUB-1 disease: carcinoma, transitional cell
VMRC-LCD cell line derived from lung
VMRC-MELG cell line derived from skin
VMRC-RCW A immortal human kidney-derived cell line cell that has the characteristics: Human renal cell carcinoma cell line. TKG0447(Deposited from Tohoku Univ.).
VMRC-RCZ Human renal carcinoma cell line.
WIL2-NS Spleen; B lymphocyte; hereditary spherocytosis cell line, established from a caucasion 5 year old male. The line was derived from the WIL-2 B cell line.
WM-115
WM1552C disease: primary superficial spreading melanoma in radial growth phase/vertical growth phase
WM278 This cell line was established from skin taken from a patient with primary nodular melanoma in vertical growth phase.
WM35 Human melanoma cell line, derived from the primary radial growth phase tumor site.
WM793B The WM793B line was established from skin taken from the primary melanoma of a vertical growth phase lesion taken from the sternum of a patient.
WSU-DLCL2 cell line derived from haematopoietic_and_lymphoid_tissue
WSU-NHL
YAPC
YH-13
YKG-1 A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0453(Deposited from Tohoku Univ.).
YMB-1-E Human breast cancer cell line; established from a 55 year-old female.
YT Human T/NK cell leukemia cell line, established from the pericardial fluid of a 15-year-old man with acute lymphoblastic leukemia (ALL) at relapse (with accompanying thymoma) in 1983.
ZR-75-30